JUAN P CATA to Head and Neck Neoplasms
This is a "connection" page, showing publications JUAN P CATA has written about Head and Neck Neoplasms.
Connection Strength
0.383
-
Intraoperative opioids use for laryngeal squamous cell carcinoma surgery and recurrence: a retrospective study. J Clin Anesth. 2015 Dec; 27(8):672-9.
Score: 0.182
-
Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor. J Cell Physiol. 2021 11; 236(11):7698-7710.
Score: 0.068
-
Mu-opioid receptor activation promotes in vitro and in vivo tumor growth in head and neck squamous cell carcinoma. Life Sci. 2021 Aug 01; 278:119541.
Score: 0.067
-
Mu-Opioid Receptor Expression in Laryngeal Cancer. J Voice. 2023 May; 37(3):433-439.
Score: 0.067